Neovasc Inc.
Neovasc Inc. (NVCN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nvcn · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Neovasc Inc.You NVCN | $83M | N/A | — | -$15.07 |
 Asensus Surgical, Inc. ASXC | $95M | N/A | — | -$0.31 |
 Berkeley Lights, Inc. BLI | $87M | N/A | — | -$1.42 |
 IGM Biosciences, Inc. IGMS | $77M | N/A | — | -$3.24 |
 Insight Molecular Diagnostics Inc. IMDX | $161M | N/A | — | -$1.65 |
 Jade Biosciences, Inc. JBIO | $495M | N/A | — | -$4.06 |
 Lifeward Ltd. LFWD | $11M | N/A | — | -$1.72 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Neovasc Inc. (NVCN) measures how much investors pay for each dollar of the company's trailing earnings. NVCN's current PE ratio of N/A is calculated by dividing its stock price of $30.03 by its TTM earnings per share of -$15.07.
Frequently asked questions
NVCN pe ratio · 6 questionsNVCN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $30.03 and TTM EPS of -$15.07. Data sourced from Financial Modeling Prep via NVCN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Neovasc Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09